Data from studies evaluating ibrexafungerp in serious fungal infections will be presented JERSEY CITY, N.J.,…
NGM831 and NGM438, NGM Bio’s myeloid reprogramming antibody product candidates targeting stromal checkpoints, will be…
New York, NY, and Tel Aviv, ISRAEL, April 20, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Todos…
CAMBRIDGE, Mass., April 20, 2022 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced…
Presentation to review historic issues related to glaucoma therapies and how these may be addressed…
PRINCETON, N.J., April 20, 2022 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader…
CAMBRIDGE, Mass., April 20, 2022 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage…
Elusys becomes wholly-owned biodefense subsidiary of NightHawk Plans to expand ANTHIM® distribution abroad DURHAM, N.C.,…
FLORHAM PARK, N.J., April 20, 2022 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
New services include pathogen identification, microbiome profiling and rapid turnaround sequencing of clinical isolates ROCKVILLE,…
Groundbreaking partnership includes debut of Lowell Farms-branded lighters within the Zippo portfolio SALINAS, Calif., April 20,…
*** David Reardon, Luigi Naldini, Brad Loncar *** MILAN, Italy and NEW YORK, April 20,…
Clinical benefit again observed for OTO-413 versus placebo for multiple efficacy endpoints based on responder…
–94% cumulative protective effect against COVID-19 in previously-infected individuals that subsequently received Clover’s COVID-19 vaccine…
Please read the full announcement in the attached PDF Attachment 2022_12_Reduction_of_share_capital
– 356 IPF Patients Enrolled – – Topline Data Anticipated Mid-2023 – SAN FRANCISCO, April…
Over 40% of Long COVID Patients Had Fibromyalgia-Like Multi-Site Pain Symptoms Rate of Opioid Use…
LOS ANGELES, April 20, 2022 (GLOBE NEWSWIRE) — Enochian BioSciences (NASDAQ: ENOB). Enochian BioSciences Inc.,…
OLINVYK showed a statistically significant reduced impact on respiratory function compared to IV morphine, among…
Oslo, Norway, 20 April 2022 Vistin Pharma ASA will release its first quarter 2022 results…